Alex M.

Strategic Business Analyst at Sentry Biopharma Services

Indianapolis Indiana UNITED STATES

Andrew Robertson

AVP, Head of Regulatory Science and Policy, NA at Sanofi

Bethesda MD UNITED STATES

Barbara Sosnowski

Vice President and Global Head – External R&D Innovation at Pfizer Inc.

New York New York UNITED STATES

Brian M.

Counsel at Arent Fox LLP

Washington District of Columbia UNITED STATES

Caroline D.

Gestionnaire de comptes et coordination at Biron Groupe Santé

Brossard QC CANADA

Chris Garabedian

Chairman and CEO at Xontogeny, LLC

Boston Massachusetts UNITED STATES

Christine Brennan

Partner at Merck MRL Ventures Fund

Kenilworth Kenilworth UNITED STATES

Christopher Haskell

Vice President and Head of the West Coast Innovation Center at Bayer Pharma AG

San Francisco California UNITED STATES

Christopher R.

Scientific Intelligence Lead at Takeda Oncology

Cambridge Massachusetts UNITED STATES

Daniel Anderson

Head of Commercial Partnerships at InVitae Corporation

San Francisco California UNITED STATES

Dhanashree C.

Northeastern University

Boston MA UNITED STATES

Dr. Julien Pham

President and Chief Operating Officer at Genprex, Inc.

Austin Texas UNITED STATES

Dr. Alborz Mahdavi

President and Chief Executive Officer at Protomer Technologies Inc.

Pasadena California                   UNITED STATES

Dr. Alexander Natz

Secretary General at European Confederation of Pharmaceutical Entrepreneurs (Belgium)

Brussels BELGIUM

Dr. Arda Ural

Partner at EY

New York New York UNITED STATES

Dr. Bhawanjit Brar

CEO at Jaan Biotherapeutics LLC

San Diego San Diego UNITED STATES

Dr. Bruce Gellin

President at Sabine Institute

Washington District Of Columbia UNITED STATES

Dr. Debra Webster, PhD

Principal Scientist at Cardinal Health Regulatory Sciences

Overland Park Kansas UNITED STATES

Dr. Denis Gauvreau

Director of International Affairs at GIP Genopole

Evry FRANCE

Dr. Jakob Reiser

Office of Tissues and Advanced Therapies Division of Cellular and Gene Therapies at FDA/CBER